Does [ Subconjunctival interleukin-1 receptor antagonist inhibit graft rejection following high-risk penetrating keratoplasty in rats ]?
Treatment with IL-1ra may significantly prolong high-risk corneal allograft survival.
Taken together, the present study suggests, for the first time, that CSG may represent promising new chemical entity which preferentially targets various tumor cells by triggering apoptosis.